Back

Factors that increase the risk of hepatocarcinoma in Fontan-associated liver disease (FALD) and new biomarkers of FALD by proteomic analysis

31 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders Congenital Heart Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yoshihito Morimoto

National Cerebral & Cardiovascular Center, Suita (Japan)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor K. Sughimoto (Chiba, JP)
Abstract Video
Presentation thumbnail
Ms K. Lee (Singapore, SG)
Abstract
Presentation thumbnail
Doctor M. Al Zaidi (Bonn, DE)
Abstract
Presentation thumbnail
Doctor S. Zheng (Bern, CH)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders

The Event

Event poster

ESC Congress 2025

31 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
A surveillance for advanced liver disease and characterization of hyperechogenic lesions after Fontan surgery in a prospective cohort of cases with congenital univentricular heart.
thumbnail
Congress Presentation
Early detection of liver fibrosis in patients with Fontan circulation using multiparametric magnetic resonance imaging
thumbnail
Congress Presentation
Linking antibody against apolipoprotein A-1 to metabolic dysfunction-associated steatohepatitis in mice

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources